Former Sanofi CEO Chris Viehbacher was handed the keys to a big biotech fund from Gurnet Point Capital a few months ago, and today he announced what he’s doing with it. Viehbacher (pictured above) will become the chairman of a new company, based in Cambridge, MA, called Boston Pharmaceuticals.